{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:18:27Z","timestamp":1783023507004,"version":"3.54.6"},"reference-count":256,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["252300421428"],"award-info":[{"award-number":["252300421428"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010950","name":"Department of Science and Technology of Henan Province","doi-asserted-by":"publisher","award":["242102310378"],"award-info":[{"award-number":["242102310378"]}],"id":[{"id":"10.13039\/501100010950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010950","name":"Department of Science and Technology of Henan Province","doi-asserted-by":"publisher","award":["235101610047"],"award-info":[{"award-number":["235101610047"]}],"id":[{"id":"10.13039\/501100010950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011841","name":"Xinxiang Medical University","doi-asserted-by":"publisher","award":["XYBSKYZZ202009"],"award-info":[{"award-number":["XYBSKYZZ202009"]}],"id":[{"id":"10.13039\/501100011841","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011841","name":"Xinxiang Medical University","doi-asserted-by":"publisher","award":["XYBSKYZZ201924"],"award-info":[{"award-number":["XYBSKYZZ201924"]}],"id":[{"id":"10.13039\/501100011841","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.yexmp.2026.105031","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T17:10:10Z","timestamp":1770311410000},"page":"105031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanisms and strategies for reversing NK cell exhaustion in tumor immunotherapy"],"prefix":"10.1016","volume":"145","author":[{"given":"Lingtong","family":"Zhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2026.105031_bb0005","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/icb.2013.99","article-title":"TLR-mediated activation of NK cells and their role in bacterial\/viral immune responses in mammals","volume":"92","author":"Adib-Conquy","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.yexmp.2026.105031_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/agm2.12292","article-title":"Gut microbes as medical signature for the effectiveness of immunotherapy in patients with advanced non-small cell lung cancer","volume":"7","author":"Adugna","year":"2024","journal-title":"Aging Med. (Milton)"},{"issue":"14","key":"10.1016\/j.yexmp.2026.105031_bb0015","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127729","article-title":"Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway","volume":"5","author":"Alvarez","year":"2019","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andre","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.yexmp.2026.105031_bb0025","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1172\/JCI74337","article-title":"Cytokine therapy reverses NK cell anergy in MHC-deficient tumors","volume":"124","author":"Ardolino","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb0030","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1080\/10408398.2011.619671","article-title":"Immune system stimulation by probiotic microorganisms","volume":"54","author":"Ashraf","year":"2014","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"8","key":"10.1016\/j.yexmp.2026.105031_bb0035","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41590-020-0728-z","article-title":"The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies","volume":"21","author":"Bald","year":"2020","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.yexmp.2026.105031_bb0040","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1002\/eji.201343448","article-title":"Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC","volume":"43","author":"Balsamo","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105031_bb0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1158\/2326-6066.CIR-14-0018","article-title":"Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity","volume":"3","author":"Bastid","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.yexmp.2026.105031_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioelechem.2021.107871","article-title":"Cell death due to electroporation - a review","volume":"141","author":"Batista Napotnik","year":"2021","journal-title":"Bioelectrochemistry"},{"issue":"18","key":"10.1016\/j.yexmp.2026.105031_bb0055","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1158\/1078-0432.CCR-15-0304","article-title":"A phase I trial of the anti-KIR antibody IPH2101 and Lenalidomide in patients with relapsed\/refractory multiple myeloma","volume":"21","author":"Benson","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004244","article-title":"Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity","volume":"10","author":"Bernard","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006002","article-title":"TIPE2 deletion improves the therapeutic potential of adoptively transferred NK cells","volume":"11","author":"Bi","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.yexmp.2026.105031_bb0070","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/2159-8290.CD-15-0944","article-title":"Suppression of metastases using a new lymphocyte checkpoint target for cancer immunotherapy","volume":"6","author":"Blake","year":"2016","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0075","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00262-006-0272-1","article-title":"Contribution of the PD-L1\/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion","volume":"56","author":"Blank","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.yexmp.2026.105031_bb0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.immunol.24.021605.090612","article-title":"Development of human lymphoid cells","volume":"24","author":"Blom","year":"2006","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb0085","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/2326-6066.CIR-17-0604","article-title":"Drug-induced senescent multiple myeloma cells elicit NK cell proliferation by direct or exosome-mediated IL15 trans-presentation","volume":"6","author":"Borrelli","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0090","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12885-024-11979-3","article-title":"Role of beta- (1\u21923) (1\u21926)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures","volume":"24","author":"Boulifa","year":"2024","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.yexmp.2026.105031_bb0095","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/eji.201041361","article-title":"Activating NK cell receptor expression\/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment","volume":"41","author":"Bozzano","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung Cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb0105","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41571-024-00903-0","article-title":"Current understanding and management of CAR T cell-associated toxicities","volume":"21","author":"Brudno","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2026.105031_bb0110","doi-asserted-by":"crossref","first-page":"576","DOI":"10.3389\/fimmu.2015.00576","article-title":"Augmented IFN-gamma and TNF-alpha induced by probiotic Bacteria in NK cells mediate differentiation of stem-like tumors leading to inhibition of tumor growth and reduction in inflammatory cytokine release; regulation by IL-10","volume":"6","author":"Bui","year":"2015","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb0115","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.3390\/cancers12071755","article-title":"Roles of NK cell receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in cancer","volume":"2","author":"Buller","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb0120","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1200\/JCO.2008.19.2435","article-title":"Phase I\/II trial of tremelimumab in patients with metastatic melanoma","volume":"27","author":"Camacho","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb0125","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.0730640100","article-title":"Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells","volume":"100","author":"Castriconi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexmp.2026.105031_bb0130","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73699","article-title":"Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors","volume":"11","author":"Chambers","year":"2022","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0135","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ni.2850","article-title":"The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions","volume":"15","author":"Chan","year":"2014","journal-title":"Nat. Immunol."},{"issue":"20","key":"10.1016\/j.yexmp.2026.105031_bb0140","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1158\/1078-0432.CCR-20-0575","article-title":"IL15 stimulation with TIGIT blockade reverses CD155-mediated NK-cell dysfunction in melanoma","volume":"26","author":"Chauvin","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2026.105031_bb0145","article-title":"Autologous NK cells propagated and activated ex vivo decrease senescence markers in human PBMCs","volume":"32","author":"Chelyapov","year":"2022","journal-title":"Biochem. Biophys. Rep."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0150","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12967-023-04112-8","article-title":"Comprehensive single-cell transcriptomic and proteomic analysis reveals NK cell exhaustion and unique tumor cell evolutionary trajectory in non-keratinizing nasopharyngeal carcinoma","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.yexmp.2026.105031_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003894","article-title":"Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities","volume":"9","author":"Christodoulou","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.yexmp.2026.105031_bb0160","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3389\/fimmu.2019.02078","article-title":"Human NK cell development: one road or many?","volume":"10","author":"Cichocki","year":"2019","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.yexmp.2026.105031_bb0165","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.3390\/ijms20153715","article-title":"DNAM-1 activating receptor and its ligands: how do viruses affect the NK cell-mediated immune surveillance during the various phases of infection?","volume":"20","author":"Cifaldi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2026.105031_bb0170","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2741\/2735","article-title":"Regulation of NK cell activity by 2B4, NTB-A and CRACC","volume":"13","author":"Claus","year":"2008","journal-title":"Front. Biosci."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0175","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.coi.2012.12.003","article-title":"T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment","volume":"25","author":"Crespo","year":"2013","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0180","first-page":"1400","article-title":"NK cell-produced IFN-gamma regulates cell growth and apoptosis of colorectal cancer by regulating IL-15","volume":"19","author":"Cui","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0185","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/2326-6066.CIR-13-0171","article-title":"Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade","volume":"2","author":"da Silva","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"16","key":"10.1016\/j.yexmp.2026.105031_bb0190","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1016\/j.cell.2025.07.007","article-title":"iPSC-derived CAR-NK cells: off-the-shelf cellular therapy for systemic sclerosis","volume":"188","author":"Daher","year":"2025","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.yexmp.2026.105031_bb0195","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.3390\/cancers16152630","article-title":"Lck function and modulation: immune cytotoxic response and tumor treatment more than a simple event","volume":"16","author":"De Sanctis","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb0200","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3390\/cells10071777","article-title":"KIR receptors as key regulators of NK cells activity in health and disease","volume":"10","author":"Debska-Zielkowska","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb0205","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ni.3470","article-title":"CIS is a potent checkpoint in NK cell-mediated tumor immunity","volume":"17","author":"Delconte","year":"2016","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0210","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/bcpt.14002","article-title":"Small-molecule inhibitor HI-TOPK-032 improves NK-92MI cell infiltration into ovarian tumours","volume":"134","author":"Deng","year":"2024","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105031_bb0215","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cell.2020.01.022","article-title":"Tissue determinants of human NK cell development, function, and residence","volume":"180","author":"Dogra","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.yexmp.2026.105031_bb0220","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1073\/pnas.1319269111","article-title":"TGF-beta-inducible microRNA-183 silences tumor-associated natural killer cells","volume":"111","author":"Donatelli","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.yexmp.2026.105031_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303963","article-title":"Mno (x) Nanoenzyme armed CAR-NK cells enhance solid tumor immunotherapy by alleviating the immunosuppressive microenvironment","volume":"13","author":"Duan","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.yexmp.2026.105031_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148111","article-title":"Immune checkpoints on T and NK cells in the context of HBV infection: landscape, pathophysiology and therapeutic exploitation","volume":"14","author":"Dumolard","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.yexmp.2026.105031_bb0235","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.4049\/jimmunol.179.8.5523","article-title":"The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands","volume":"179","author":"Elsner","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexmp.2026.105031_bb0240","article-title":"Single-cell RNA-seq reveals T cell exhaustion and immune response landscape in osteosarcoma","volume":"15","author":"Fan","year":"2024","journal-title":"Front. Immunol."},{"issue":"6205","key":"10.1016\/j.yexmp.2026.105031_bb0245","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/337387a0","article-title":"Cationic liposome-mediated transfection","volume":"337","author":"Felgner","year":"1989","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.yexmp.2026.105031_bb0250","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96219","article-title":"Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect","volume":"3","author":"Felices","year":"2018","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.yexmp.2026.105031_bb0255","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1167\/iovs.08-3215","article-title":"Regulation of cross-linked actin network (CLAN) formation in human trabecular meshwork (HTM) cells by convergence of distinct beta1 and beta3 integrin pathways","volume":"50","author":"Filla","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.yexmp.2026.105031_bb0260","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-3083.2003.01347.x","article-title":"Natural killer cell-mediated basal and interferon-enhanced cytotoxicity against liver cancer cells is significantly impaired under in vivo oxygen conditions","volume":"58","author":"Fink","year":"2003","journal-title":"Scand. J. Immunol."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb0265","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.4049\/jimmunol.172.7.3994","article-title":"Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155)","volume":"172","author":"Fuchs","year":"2004","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.yexmp.2026.105031_bb0270","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ni.3800","article-title":"Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells","volume":"18","author":"Gao","year":"2017","journal-title":"Nat. Immunol."},{"issue":"21","key":"10.1016\/j.yexmp.2026.105031_bb0275","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.yexmp.2026.105031_bb0280","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1158\/0008-5472.CAN-04-3804","article-title":"Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells","volume":"65","author":"Gastpar","year":"2005","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0285","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cac2.12394","article-title":"Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors","volume":"43","author":"Ghaedrahmati","year":"2023","journal-title":"Cancer Commun. (Lond.)"},{"issue":"10473","key":"10.1016\/j.yexmp.2026.105031_bb0290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(24)02462-0","article-title":"Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial","volume":"405","author":"Ghobadi","year":"2025","journal-title":"Lancet (London, England)"},{"issue":"13","key":"10.1016\/j.yexmp.2026.105031_bb0295","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2011-06-360321","article-title":"Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9","volume":"119","author":"Gleason","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.yexmp.2026.105031_bb0300","first-page":"269","article-title":"LAG-3 in Cancer immunotherapy","volume":"344","author":"Goldberg","year":"2011","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"9","key":"10.1016\/j.yexmp.2026.105031_bb0305","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1219007","article-title":"Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma","volume":"5","author":"Granzin","year":"2016","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.yexmp.2026.105031_bb0310","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1158\/1078-0432.CCR-19-2625","article-title":"Inhibition of MDSC trafficking with SX-682, a CXCR1\/2 inhibitor, enhances NK-cell immunotherapy in head and neck cancer models","volume":"26","author":"Greene","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0315","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1172\/JCI77181","article-title":"Immunosurveillance and therapy of multiple myeloma are CD226 dependent","volume":"125","author":"Guillerey","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexmp.2026.105031_bb0320","article-title":"Feeder cells at the Interface of natural killer cell activation","volume":"13","author":"Gurney","year":"2022","journal-title":"Expansion and Gene Editing. Front Immunol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0325","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma","volume":"369","author":"Hamid","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.yexmp.2026.105031_bb0330","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.3390\/ijms25158209","article-title":"Comparison of natural killer cells differentiated from various pluripotent stem cells","volume":"25","author":"Han","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0335","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1158\/2326-6066.CIR-18-0481","article-title":"Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK cells in colorectal liver metastasis","volume":"7","author":"Harmon","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"12","key":"10.1016\/j.yexmp.2026.105031_bb0340","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007502","article-title":"Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic fc-active TIGIT antibodies","volume":"11","author":"Hasan","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"10","key":"10.1016\/j.yexmp.2026.105031_bb0345","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00262-011-1040-4","article-title":"Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity","volume":"60","author":"Hausler","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105031_bb0350","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/bcpt.13841","article-title":"The adhesion G protein-coupled receptor GPR56\/ADGRG1 in cytotoxic lymphocytes","volume":"133","author":"Hsiao","year":"2023","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.yexmp.2026.105031_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.761920","article-title":"Expression regulation and function of T-bet in NK cells","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Immunol."},{"issue":"7534","key":"10.1016\/j.yexmp.2026.105031_bb0360","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature13848","article-title":"CEACAM1 regulates TIM-3-mediated tolerance and exhaustion","volume":"517","author":"Huang","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0365","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s11684-024-1090-6","article-title":"Intracellular checkpoints for NK cell cancer immunotherapy","volume":"18","author":"Huang","year":"2024","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40164-024-00592-6","article-title":"Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed\/refractory AML: preclinical evaluation and phase I trial","volume":"14","author":"Huang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0375","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/1521-4141(200202)32:2<374::AID-IMMU374>3.0.CO;2-9","article-title":"Exhaustion of cytotoxic T cells during adoptive immunotherapy of virus carrier mice can be prevented by B cells or CD4+ T cells","volume":"32","author":"Hunziker","year":"2002","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105031_bb0380","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.yexmp.2026.105031_bb0385","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26383","article-title":"Tumor-derived lactate and myeloid-derived suppressor cells: linking metabolism to cancer immunology","volume":"2","author":"Husain","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.yexmp.2026.105031_bb0390","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jconrel.2023.11.001","article-title":"Cationic amino-acid functionalized polymethacrylamide vectors for siRNA transfection based on modification of poly (2-isopropenyl-2-oxazoline)","volume":"364","author":"Jerca","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.yexmp.2026.105031_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1303605","article-title":"NK cell exhaustion in the tumor microenvironment","volume":"14","author":"Jia","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2026.105031_bb0400","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fcimb.2020.00049","article-title":"Characterizing the dysfunctional NK cell: assessing the clinical relevance of exhaustion, Anergy, and senescence","volume":"10","author":"Judge","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"13","key":"10.1016\/j.yexmp.2026.105031_bb0405","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMc1108661","article-title":"Ipilimumab plus dacarbazine in melanoma","volume":"365","author":"Kaplan","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.yexmp.2026.105031_bb0410","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","article-title":"Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice","volume":"95","author":"Kaplan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0415","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00296-024-05772-5","article-title":"Safety and efficacy of CAR-T cell therapy in patients with autoimmune diseases: a systematic review","volume":"45","author":"Kattamuri","year":"2025","journal-title":"Rheumatol. Int."},{"issue":"13","key":"10.1016\/j.yexmp.2026.105031_bb0420","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1158\/1078-0432.CCR-21-0164","article-title":"Combining AFM13, a bispecific CD30\/CD16 antibody, with cytokine-activated blood and cord blood-derived NK cells facilitates CAR-like responses against CD30 (+) malignancies","volume":"27","author":"Kerbauy","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.yexmp.2026.105031_bb0425","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jcyt.2025.05.008","article-title":"Feeder cell-free production of CAR-NK cells via activation of PKC and calcium signaling pathways","volume":"27","author":"Khanal","year":"2025","journal-title":"Cytotherapy"},{"key":"10.1016\/j.yexmp.2026.105031_bb0430","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3389\/fimmu.2018.02041","article-title":"Targeting checkpoint receptors and molecules for therapeutic modulation of natural killer cells","volume":"9","author":"Kim","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2026.105031_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119418","article-title":"Multifunctional nanoparticles for genetic engineering and bioimaging of natural killer (NK) cell therapeutics","volume":"221","author":"Kim","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.yexmp.2026.105031_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116436","article-title":"CD19 CAR-expressing iPSC-derived NK cells effectively enhance migration and cytotoxicity into glioblastoma by targeting to the pericytes in tumor microenvironment","volume":"174","author":"Kong","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexmp.2026.105031_bb0445","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3389\/fphys.2016.00626","article-title":"Abbott MJ. IL-15 activates the Jak3\/STAT3 signaling pathway to mediate glucose uptake in skeletal muscle cells","volume":"7","author":"Krolopp","year":"2016","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0450","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3390\/ijms24021337","article-title":"The machinery of exosomes: biogenesis, release, and uptake","volume":"24","author":"Krylova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"764","key":"10.1016\/j.yexmp.2026.105031_bb0455","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp0004","article-title":"BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML","volume":"16","author":"Kumar","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0460","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13045-022-01382-5","article-title":"Natural killer cells in clinical development as non-engineered, engineered, and combination therapies","volume":"15","author":"Lamers-Kok","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.yexmp.2026.105031_bb0465","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.3389\/fimmu.2019.03010","article-title":"Recalling the biological significance of immune checkpoints on NK cells: a chance to overcome LAG3, PD1, and CTLA4 inhibitory pathways by adoptive NK cell transfer?","volume":"10","author":"Lanuza","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0470","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3150","article-title":"Gene transfer to skeletal muscle using hydrodynamic limb vein injection: current applications, hurdles and possible optimizations","volume":"22","author":"Le Guen","year":"2020","journal-title":"J. Gene Med."},{"issue":"1\u20132","key":"10.1016\/j.yexmp.2026.105031_bb0475","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-2478(91)90197-I","article-title":"The relationship between MHC restricted and allospecific T cell recognition","volume":"29","author":"Lechler","year":"1991","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0480","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006130","article-title":"Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6","volume":"11","author":"Lee","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0485","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s43018-025-00940-3","article-title":"Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory\/relapsed large B cell lymphoma: a phase 1 trial","volume":"6","author":"Lei","year":"2025","journal-title":"Nat Cancer."},{"issue":"7658","key":"10.1016\/j.yexmp.2026.105031_bb0490","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature22360","article-title":"Stability and function of regulatory T cells expressing the transcription factor T-bet","volume":"546","author":"Levine","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0495","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.gastro.2012.10.039","article-title":"Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice","volume":"144","author":"Li","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.yexmp.2026.105031_bb0500","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.chom.2013.09.007","article-title":"The NK receptor NKp30 mediates direct fungal recognition and killing and is diminished in NK cells from HIV-infected patients","volume":"14","author":"Li","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0505","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000131","article-title":"CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency","volume":"8","author":"Li","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27196","article-title":"CAR-NK cells in combination therapy against cancer: a potential paradigm","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0515","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.7150\/ijbs.88539","article-title":"NK-92MI cells engineered with anti-claudin-6 chimeric antigen receptors in immunotherapy for ovarian Cancer","volume":"20","author":"Li","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexmp.2026.105031_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111918","article-title":"SFXN1-mediated immune cell infiltration and tumorigenesis in lung adenocarcinoma: a potential therapeutic target","volume":"132","author":"Li","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0525","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s12282-025-01738-y","article-title":"Emerging roles of KIR2DL4 in cancer immunotherapy","volume":"32","author":"Li","year":"2025","journal-title":"Breast Cancer"},{"key":"10.1016\/j.yexmp.2026.105031_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2025.100677","article-title":"Emerging trends in clinical allogeneic CAR cell therapy","volume":"6","author":"Li","year":"2025","journal-title":"Med"},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb0535","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/s41590-024-01861-6","article-title":"Eomes expression identifies the early bone marrow precursor to classical NK cells","volume":"25","author":"Liang","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.yexmp.2026.105031_bb0540","article-title":"Efficacy of the induced pluripotent stem cell derived and engineered CD276-targeted CAR-NK cells against human esophageal squamous cell carcinoma","volume":"15","author":"Lin","year":"2024","journal-title":"Front. Immunol."},{"issue":"44","key":"10.1016\/j.yexmp.2026.105031_bb0545","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1038\/onc.2017.209","article-title":"Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers","volume":"36","author":"Liu","year":"2017","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.yexmp.2026.105031_bb0550","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1021\/acsnano.9b10103","article-title":"Boosting natural killer cell-based Cancer immunotherapy with Selenocystine\/transforming growth factor-Beta inhibitor-encapsulated Nanoemulsion","volume":"14","author":"Liu","year":"2020","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0555","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","article-title":"NK cell-based cancer immunotherapy: from basic biology to clinical development","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0560","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1038\/s41467-022-34495-z","article-title":"Single cell sequencing reveals that CD39 inhibition mediates changes to the tumor microenvironment","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0565","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","article-title":"Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0570","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s12672-024-01679-6","article-title":"The roles of LncRNA CARMN in cancers: biomarker potential, therapeutic targeting, and immune response","volume":"15","author":"Liu","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.yexmp.2026.105031_bb0575","doi-asserted-by":"crossref","first-page":"105","DOI":"10.21037\/atm.2019.01.42","article-title":"NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives (5)","volume":"7","author":"Lo Nigro","year":"2019","journal-title":"Ann. Transl. Med."},{"issue":"9","key":"10.1016\/j.yexmp.2026.105031_bb0580","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1002\/cam4.1713","article-title":"Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma","volume":"7","author":"Long","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.yexmp.2026.105031_bb0585","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3541283","article-title":"NK cell-dependent growth inhibition of Lewis lung Cancer by Yu-ping-Feng, an ancient Chinese herbal formula","volume":"2016","author":"Luo","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0590","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-025-02158-2","article-title":"Neoleukin-2\/15-armored CAR-NK cells sustain superior therapeutic efficacy in solid tumors via c-Myc\/NRF1 activation","volume":"10","author":"Luo","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0595","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/s41467-024-46343-3","article-title":"synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy","volume":"15","author":"Lupo","year":"2024","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.yexmp.2026.105031_bb0600","doi-asserted-by":"crossref","first-page":"15874","DOI":"10.1074\/jbc.M112.340588","article-title":"Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro","volume":"287","author":"Lv","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105031_bb0605","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10544-017-0204-1","article-title":"Non-electrolytic microelectroporation","volume":"19","author":"Lyu","year":"2017","journal-title":"Biomed. Microdevices"},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0610","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-017-0665-0","article-title":"Blockade of adenosine A2A receptor enhances CD8 (+) T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma","volume":"16","author":"Ma","year":"2017","journal-title":"Mol. Cancer"},{"issue":"13","key":"10.1016\/j.yexmp.2026.105031_bb0615","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1158\/0008-5472.CAN-21-0035","article-title":"An oncolytic virus expressing IL15\/IL15Ralpha combined with off-the-shelf EGFR-CAR NK cells targets glioblastoma","volume":"81","author":"Ma","year":"2021","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.yexmp.2026.105031_bb0620","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.it.2022.08.004","article-title":"Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy","volume":"43","author":"Ma","year":"2022","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0625","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.trecan.2022.10.003","article-title":"The emerging field of oncolytic virus-based cancer immunotherapy","volume":"9","author":"Ma","year":"2023","journal-title":"Trends Cancer"},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0630","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/cells13050451","article-title":"Building a better defense: expanding and improving natural killer cells for adoptive cell therapy","volume":"13","author":"Maia","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.yexmp.2026.105031_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.767530","article-title":"The natural cytotoxicity receptor NKp44 (NCR2, CD336) is expressed on the majority of porcine NK cells ex vivo without stimulation","volume":"13","author":"Mair","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.yexmp.2026.105031_bb0640","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI45816","article-title":"Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity","volume":"121","author":"Mamessier","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105031_bb0645","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri3799","article-title":"Balancing natural killer cell activation through paired receptors","volume":"15","author":"Martinet","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"15","key":"10.1016\/j.yexmp.2026.105031_bb0650","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/blood-2010-01-261404","article-title":"CD137 in NK cells","volume":"115","author":"Marvel","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.yexmp.2026.105031_bb0655","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ng.343","article-title":"Molecular evolution of a novel hyperactive sleeping beauty transposase enables robust stable gene transfer in vertebrates","volume":"41","author":"Mates","year":"2009","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.yexmp.2026.105031_bb0660","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1226720","article-title":"Therapeutic CD94\/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia","volume":"5","author":"McWilliams","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.yexmp.2026.105031_bb0665","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ebiom.2019.01.031","article-title":"NK cells specifically TCR-dressed to kill cancer cells","volume":"40","author":"Mensali","year":"2019","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.yexmp.2026.105031_bb0670","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI125916","article-title":"Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming","volume":"129","author":"Merino","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105031_bb0675","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/JLB.4MR0620-091R","article-title":"Unraveling exhaustion in adaptive and conventional NK cells","volume":"108","author":"Merino","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0680","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105031_bb0685","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1074-7613(02)00286-8","article-title":"Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation","volume":"16","author":"Metkar","year":"2002","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.yexmp.2026.105031_bb0690","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/FJC.0000000000000821","article-title":"Transduction efficiency of adenovirus vectors in endothelial cells and vascular smooth muscle cells","volume":"75","author":"Mokhashi","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105031_bb0695","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.yexmp.2026.105031_bb0700","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1021\/acs.molpharmaceut.1c00085","article-title":"Reversing hypoxia with PLGA-encapsulated manganese dioxide nanoparticles improves natural killer cell response to tumor spheroids","volume":"18","author":"Murphy","year":"2021","journal-title":"Mol. Pharm."},{"issue":"15","key":"10.1016\/j.yexmp.2026.105031_bb0705","article-title":"Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion","volume":"7","author":"Myers Ja Fau - Schirm","year":"2022","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.yexmp.2026.105031_bb0710","article-title":"Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV","volume":"2","author":"Naeimi Kararoudi","year":"2022","journal-title":"Cell Rep Methods."},{"key":"10.1016\/j.yexmp.2026.105031_bb0715","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.yexmp.2026.105031_bb0720","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1182\/blood-2011-11-392951","article-title":"Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity","volume":"119","author":"Ndhlovu","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.yexmp.2026.105031_bb0725","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1172\/JCI128895","article-title":"CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment","volume":"130","author":"Neo","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"747","key":"10.1016\/j.yexmp.2026.105031_bb0730","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi2952","article-title":"Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6\/STAT3 axis","volume":"16","author":"Neo","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.yexmp.2026.105031_bb0735","doi-asserted-by":"crossref","DOI":"10.4161\/onci.24462","article-title":"BRAF-targeted therapy and immune responses to melanoma","volume":"2","author":"Ngiow","year":"2013","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0740","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.annonc.2021.11.002","article-title":"First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer (\u2606)","volume":"33","author":"Niu","year":"2022","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0745","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41577-019-0139-2","article-title":"Immunometabolism and natural killer cell responses","volume":"19","author":"O\u2019Brien","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexmp.2026.105031_bb0750","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.immuni.2015.09.013","article-title":"Natural killer cell memory","volume":"43","author":"O\u2019Sullivan","year":"2015","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.yexmp.2026.105031_bb0755","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1007\/s11033-020-05343-4","article-title":"Gene transfer to plants by electroporation: methods and applications","volume":"47","author":"Ozyigit","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105031_bb0760","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/biomedicines12030650","article-title":"The hTERT and iCasp9 transgenes affect EOMES and T-BET levels in NK cells and the introduction of both genes improves NK cell proliferation in response to IL2 and IL15 stimulation","volume":"12","author":"Palamarchuk","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.yexmp.2026.105031_bb0765","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2147\/CMAR.S193174","article-title":"Trametes robiniophila Murr: a traditional Chinese medicine with potent anti-tumor effects","volume":"11","author":"Pan","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"23","key":"10.1016\/j.yexmp.2026.105031_bb0770","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202211370","article-title":"A Nanotherapeutic strategy to reverse NK cell exhaustion","volume":"35","author":"Pan","year":"2023","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105031_bb0775","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"42","key":"10.1016\/j.yexmp.2026.105031_bb0780","doi-asserted-by":"crossref","first-page":"68513","DOI":"10.18632\/oncotarget.12097","article-title":"NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphoma","volume":"7","author":"Parry","year":"2016","journal-title":"Oncotarget"},{"issue":"76","key":"10.1016\/j.yexmp.2026.105031_bb0785","article-title":"Regulation of human interferon signaling by transposon exonization","volume":"187","author":"Pasquesi","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.yexmp.2026.105031_bb0790","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3389\/fimmu.2019.01179","article-title":"Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation","volume":"10","author":"Pende","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexmp.2026.105031_bb0795","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-11-262","article-title":"Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer","volume":"11","author":"Peng","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.yexmp.2026.105031_bb0800","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy","volume":"93","author":"Perez-Herrero","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0805","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41389-017-0011-9","article-title":"The hypoxic tumour microenvironment","volume":"7","author":"Petrova","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.yexmp.2026.105031_bb0810","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-1-4939-3684-7_14","article-title":"Expansion of NK cells using genetically engineered K562 feeder cells","volume":"1441","author":"Phan","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0815","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.3390\/ijms25052917","article-title":"Restriction of glycolysis increases serial killing capacity of natural killer cells","volume":"25","author":"Picard","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2026.105031_bb0820","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.coviro.2017.06.003","article-title":"Host determinants of adeno-associated viral vector entry","volume":"24","author":"Pillay","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.yexmp.2026.105031_bb0825","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.omto.2021.11.016","article-title":"Natural killer cells and immune-checkpoint inhibitor therapy: current knowledge and new challenges","volume":"24","author":"Poggi","year":"2022","journal-title":"Mol Ther Oncolytics"},{"issue":"6","key":"10.1016\/j.yexmp.2026.105031_bb0830","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/JLB.MR0718-269R","article-title":"Mechanisms of natural killer cell-mediated cellular cytotoxicity","volume":"105","author":"Prager","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0835","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12943-023-01894-9","article-title":"Outsmarting trogocytosis to boost CAR NK\/T cell therapy","volume":"22","author":"Ramezani","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1\u20133","key":"10.1016\/j.yexmp.2026.105031_bb0840","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1385\/IR:36:1:91","article-title":"Adenosine-mediated inhibition of cytotoxic activity and cytokine production by IL-2\/NKp46-activated NK cells: involvement of protein kinase a isozyme I (PKA I)","volume":"36","author":"Raskovalova","year":"2006","journal-title":"Immunol. Res."},{"issue":"4","key":"10.1016\/j.yexmp.2026.105031_bb0845","doi-asserted-by":"crossref","first-page":"748","DOI":"10.20517\/cdr.2023.63","article-title":"Unlocking antitumor immunity with adenosine receptor blockers","volume":"6","author":"Remley","year":"2023","journal-title":"Cancer Drug Resist."},{"issue":"12","key":"10.1016\/j.yexmp.2026.105031_bb0850","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2174\/1568026033451844","article-title":"Development and potential utility of dual and triple NK receptor antagonists","volume":"3","author":"Rizzo","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0855","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/imm.13464","article-title":"NK-cell exhaustion, B-cell exhaustion and T-cell exhaustion-the differences and similarities","volume":"166","author":"Roe","year":"2022","journal-title":"Immunology"},{"issue":"5562","key":"10.1016\/j.yexmp.2026.105031_bb0860","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.yexmp.2026.105031_bb0865","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0870","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064835","article-title":"Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells","volume":"8","author":"Sarkar","year":"2013","journal-title":"PloS One"},{"issue":"16","key":"10.1016\/j.yexmp.2026.105031_bb0875","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/0008-5472.CAN-11-3873","article-title":"Primary tumor hypoxia recruits CD11b+\/Ly6Cmed\/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche","volume":"72","author":"Sceneay","year":"2012","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb0880","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat. Immunol."},{"issue":"7956","key":"10.1016\/j.yexmp.2026.105031_bb0885","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41586-023-05912-0","article-title":"The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells","volume":"616","author":"Sen Santara","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2026.105031_bb0890","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15776","article-title":"IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours","volume":"8","author":"Seo","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.yexmp.2026.105031_bb0895","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1158\/2326-6066.CIR-17-0708","article-title":"IL21 therapy combined with PD-1 and Tim-3 blockade provides enhanced NK cell antitumor activity against MHC class I-deficient tumors","volume":"6","author":"Seo","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"14","key":"10.1016\/j.yexmp.2026.105031_bb0900","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142116","article-title":"Targeting the alphav integrin\/TGF-beta axis improves natural killer cell function against glioblastoma stem cells","volume":"131","author":"Shaim","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"24","key":"10.1016\/j.yexmp.2026.105031_bb0905","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.18632\/aging.205283","article-title":"Anoikis regulator GLI2 promotes NC cell immunity escape by TGF-beta-mediated non-classic hedgehog signaling in colorectal cancer: based on artificial intelligence and big data analysis","volume":"15","author":"Shanshan","year":"2023","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"10.1016\/j.yexmp.2026.105031_bb0910","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41409-020-01134-4","article-title":"Taming the beast: CRS and ICANS after CAR T-cell therapy for ALL","volume":"56","author":"Sheth","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0915","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1084\/jem.185.5.855","article-title":"Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization","volume":"185","author":"Shi","year":"1997","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb0920","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.cell.2018.10.024","article-title":"Genome-wide CRISPR screens in primary human T cells reveal key regulators of immune function","volume":"175","author":"Shifrut","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.yexmp.2026.105031_bb0925","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.imbio.2019.03.001","article-title":"NK cell expression of Tim-3: first impressions matter","volume":"224","author":"So","year":"2019","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.yexmp.2026.105031_bb0930","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1101\/gr.277585.122","article-title":"Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data","volume":"33","author":"Song","year":"2023","journal-title":"Genome Res."},{"issue":"9","key":"10.1016\/j.yexmp.2026.105031_bb0935","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.3390\/cancers13092112","article-title":"LAG-3 blockade with Relatlimab (BMS-986016) restores anti-leukemic responses in chronic lymphocytic leukemia","volume":"13","author":"Sordo-Bahamonde","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.yexmp.2026.105031_bb0940","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1158\/2326-6066.CIR-21-1052","article-title":"TGFbeta and CIS inhibition overcomes NK-cell suppression to restore antitumor immunity","volume":"10","author":"Souza-Fonseca-Guimaraes","year":"2022","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0945","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2127508","article-title":"AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastoma","volume":"11","author":"Strecker","year":"2022","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.yexmp.2026.105031_bb0950","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002594","article-title":"TGF-beta1 down-regulation of NKG2D\/DAP10 and 2B4\/SAP expression on human NK cells contributes to HBV persistence","volume":"8","author":"Sun","year":"2012","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.yexmp.2026.105031_bb0955","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/aps.2015.41","article-title":"Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy","volume":"36","author":"Sun","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0960","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1264562","article-title":"High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer","volume":"6","author":"Sun","year":"2017","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb0965","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/hep.30347","article-title":"Human CD96 correlates to natural killer cell exhaustion and predicts the prognosis of human hepatocellular carcinoma","volume":"70","author":"Sun","year":"2019","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb0970","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.70045","article-title":"Engineered iPSC-derived natural killer cells: recent innovations in translational innate anti-cancer immunotherapy","volume":"14","author":"Sun","year":"2025","journal-title":"Clin Transl Immunology."},{"key":"10.1016\/j.yexmp.2026.105031_bb0975","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.2147\/IJN.S128032","article-title":"Chitosan nanoparticle-based delivery of fused NKG2D-IL-21 gene suppresses colon cancer growth in mice","volume":"12","author":"Tan","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb0980","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1158\/0008-5472.CAN-19-2332","article-title":"Tim-3 hampers tumor surveillance of liver-resident and conventional NK cells by disrupting PI3K signaling","volume":"80","author":"Tan","year":"2020","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105031_bb0985","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","article-title":"Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy","volume":"41","author":"Tay","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexmp.2026.105031_bb0990","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3389\/fimmu.2019.02278","article-title":"NK cell metabolism and tumor microenvironment","volume":"10","author":"Terr\u00e9n","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.yexmp.2026.105031_bb0995","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s43018-022-00448-0","article-title":"Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity","volume":"3","author":"Tian","year":"2022","journal-title":"Nat Cancer."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb1000","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.3390\/ijms24076520","article-title":"Prognostic value and genome signature of m6A\/m5C regulated genes in early-stage lung adenocarcinoma","volume":"24","author":"Tian","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb1005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12943-022-01672-z","article-title":"NK cells and solid tumors: therapeutic potential and persisting obstacles","volume":"21","author":"Tong","year":"2022","journal-title":"Mol. Cancer"},{"issue":"13","key":"10.1016\/j.yexmp.2026.105031_bb1010","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.3390\/cells12131778","article-title":"Role of CD93 in health and disease","volume":"12","author":"Tossetta","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.yexmp.2026.105031_bb1015","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1158\/1078-0432.CCR-16-1743","article-title":"TGFbetaR1 blockade with Galunisertib (LY2157299) enhances anti-neuroblastoma activity of the anti-GD2 antibody Dinutuximab (ch14.18) with natural killer cells","volume":"23","author":"Tran","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb1020","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1084\/jem.171.5.1393","article-title":"LAG-3, a novel lymphocyte activation gene closely related to CD4","volume":"171","author":"Triebel","year":"1990","journal-title":"J. Exp. Med."},{"issue":"s","key":"10.1016\/j.yexmp.2026.105031_bb1025","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.4049\/jimmunol.181.6.3784","article-title":"TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells","volume":"181","author":"Trotta","year":"2008","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.yexmp.2026.105031_bb1030","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/ijc.34389","article-title":"The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activity","volume":"152","author":"Tumino","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"8","key":"10.1016\/j.yexmp.2026.105031_bb1035","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/13543784.2018.1498081","article-title":"IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma","volume":"27","author":"Van Der Weyden","year":"2018","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb1040","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/cancers11070967","article-title":"State of the art of natural killer cell imaging: a systematic review","volume":"11","author":"Varani","year":"2019","journal-title":"Cancers (Basel)."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb1045","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/biomedicines11010064","article-title":"The latest approach of immunotherapy with endosomal TLR agonists improving NK cell function: an overview","volume":"11","author":"Veneziani","year":"2022","journal-title":"Biomedicines"},{"issue":"415","key":"10.1016\/j.yexmp.2026.105031_bb1050","doi-asserted-by":"crossref","first-page":"ra19","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-beta inhibits the activation and functions of NK cells by repressing the mTOR pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci. Signal."},{"issue":"10","key":"10.1016\/j.yexmp.2026.105031_bb1055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/cancers9100132","article-title":"Regulation of mTOR, metabolic fitness, and effector functions by cytokines in natural killer cells","volume":"9","author":"Viel","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.yexmp.2026.105031_bb1060","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3389\/fimmu.2019.00925","article-title":"Targeting adenosine in Cancer immunotherapy to enhance T-cell function","volume":"10","author":"Vigano","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.yexmp.2026.105031_bb1065","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1279372","article-title":"Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: role of HSP70\/TLR2\/NF-kB axis","volume":"6","author":"Vulpis","year":"2017","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb1070","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1038\/jidsymp.2013.8","article-title":"The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disorders","volume":"16","author":"Waldmann","year":"2013","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"issue":"3\u20134","key":"10.1016\/j.yexmp.2026.105031_bb1075","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/08830189809042995","article-title":"Interleukin-2, interleukin-15, and their receptors","volume":"16","author":"Waldmann","year":"1998","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.yexmp.2026.105031_bb1080","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fimmu.2015.00368","article-title":"NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy","volume":"6","author":"Wang","year":"2015","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.yexmp.2026.105031_bb1085","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3109\/08820139.2015.1052145","article-title":"The clinical significance of abnormal Tim-3 expression on NK cells from patients with gastric Cancer","volume":"44","author":"Wang","year":"2015","journal-title":"Immunol. Invest."},{"issue":"8","key":"10.1016\/j.yexmp.2026.105031_bb1090","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1158\/2326-6066.CIR-17-0491","article-title":"Enhanced Cancer immunotherapy with Smad3-silenced NK-92 cells","volume":"6","author":"Wang","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"11","key":"10.1016\/j.yexmp.2026.105031_bb1095","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1172\/JCI121227","article-title":"SMAD4 promotes TGF-beta-independent NK cell homeostasis and maturation and antitumor immunity","volume":"128","author":"Wang","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.yexmp.2026.105031_bb1100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/CJI.0000000000000276","article-title":"\u201cacquired\u201d NKG2D ligand stimulates NK cell-mediated tumor Immunosurveillance","volume":"42","author":"Wang","year":"2019","journal-title":"J. Immunother."},{"issue":"45","key":"10.1016\/j.yexmp.2026.105031_bb1105","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107507118","article-title":"Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells","volume":"118","author":"Wang","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexmp.2026.105031_bb1110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1250920","article-title":"Autophagy-mediated NKG2D internalization impairs NK cell function and exacerbates radiation pneumonitis","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb1115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s13402-023-00880-z","article-title":"SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma","volume":"47","author":"Wang","year":"2024","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"10.1016\/j.yexmp.2026.105031_bb1120","article-title":"CD70-targeted iPSC-derived CAR-NK cells display potent function against tumors and alloreactive T cells","volume":"6","author":"Wang","year":"2025","journal-title":"Cell Rep. Med."},{"issue":"11","key":"10.1016\/j.yexmp.2026.105031_bb1125","doi-asserted-by":"crossref","first-page":"1063 e1","DOI":"10.1016\/j.jtct.2024.07.004","article-title":"An extended flow cytometry evaluation of ex vivo expanded NK cells using K562.Clone1, a feeder cell line manufactured in Brazil","volume":"30","author":"Watanabe","year":"2024","journal-title":"Transplant Cell Ther."},{"issue":"6","key":"10.1016\/j.yexmp.2026.105031_bb1130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"issue":"13","key":"10.1016\/j.yexmp.2026.105031_bb1135","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162530","article-title":"T-BET and EOMES sustain mature human NK cell identity and antitumor function","volume":"133","author":"Wong","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb1140","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.intimp.2013.04.017","article-title":"The enhanced effect of lupeol on the destruction of gastric cancer cells by NK cells","volume":"16","author":"Wu","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yexmp.2026.105031_bb1145","doi-asserted-by":"crossref","DOI":"10.1039\/C8BM00588E","article-title":"Magnetic delivery of Fe(3)O(4)@polydopamine nanoparticle-loaded natural killer cells suggest a promising anticancer treatment","volume":"6","author":"Wu","year":"2018","journal-title":"Biomater. Sci."},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb1150","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.3390\/ijms24076843","article-title":"Engineering a HER2-CAR-NK cell secreting soluble programmed cell death protein with superior antitumor efficacy","volume":"24","author":"Xia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexmp.2026.105031_bb1155","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.molimm.2023.04.011","article-title":"Sirtuin 6 is a negative regulator of the anti-tumor function of natural killer cells in murine inflammatory colorectal cancer","volume":"158","author":"Xiao","year":"2023","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.yexmp.2026.105031_bb1160","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1111\/j.1582-4934.2009.00851.x","article-title":"Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8 (+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70","volume":"14","author":"Xie","year":"2010","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.yexmp.2026.105031_bb1165","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cmet.2014.03.003","article-title":"Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells","volume":"19","author":"Xie","year":"2014","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb1170","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.intimp.2015.09.017","article-title":"Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma","volume":"29","author":"Xu","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb1175","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7150\/ijbs.65019","article-title":"Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer","volume":"18","author":"Yan","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexmp.2026.105031_bb1180","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.brainresbull.2019.09.012","article-title":"Glioblastoma: targeting the autophagy in tumorigenesis","volume":"153","author":"Yang","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.yexmp.2026.105031_bb1185","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.omtm.2020.06.014","article-title":"Superior expansion and cytotoxicity of human primary NK and CAR-NK cells from various sources via enriched metabolic pathways","volume":"18","author":"Yang","year":"2020","journal-title":"Mol Ther Methods Clin Dev."},{"key":"10.1016\/j.yexmp.2026.105031_bb1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ultsonch.2020.105096","article-title":"Mechanisms underlying sonoporation: interaction between microbubbles and cells","volume":"67","author":"Yang","year":"2020","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.yexmp.2026.105031_bb1195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114616","article-title":"Visualization of natural killer cell-mediated killing of cancer cells at single-cell resolution in live zebrafish","volume":"216","author":"Yang","year":"2022","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.yexmp.2026.105031_bb1200","article-title":"Evaluating the transduction efficiency of systemically delivered AAV vectors in the rat nervous system","volume":"17","author":"Yang","year":"2023","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb1205","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13046-024-03002-1","article-title":"Combined IL6 and CCR2 blockade potentiates antitumor activity of NK cells in HPV-negative head and neck cancer","volume":"43","author":"Yang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2026.105031_bb1210","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104859","article-title":"Metabolic reprogramming of NK cells drives anti-tumor immunity","volume":"215","author":"Yang","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb1215","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1038\/s41598-023-30476-4","article-title":"Suppression of CEBPdelta recovers exhaustion in anti-metastatic immune cells","volume":"13","author":"Yin","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2026.105031_bb1220","article-title":"Empowering pancreatic tumor homing with augmented anti-tumor potency of CXCR2-tethered CAR-NK cells","volume":"32","author":"Yoon","year":"2024","journal-title":"Mol Ther Oncol."},{"issue":"8","key":"10.1016\/j.yexmp.2026.105031_bb1225","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.ccell.2024.06.014","article-title":"Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity","volume":"42","author":"You","year":"2024","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.yexmp.2026.105031_bb1230","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1158\/0008-5472.CAN-17-2826","article-title":"A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment","volume":"78","author":"Young","year":"2018","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.yexmp.2026.105031_bb1235","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.it.2013.07.005","article-title":"Location and cellular stages of natural killer cell development","volume":"34","author":"Yu","year":"2013","journal-title":"Trends Immunol."},{"issue":"9","key":"10.1016\/j.yexmp.2026.105031_bb1240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291254","article-title":"Rapid increase in immune surveillance and expression of NKT and gammadeltaT cell activation markers after consuming a nutraceutical supplement containing Aloe vera gel, extracts of Poria cocos and rosemary. A randomized placebo-controlled cross-over trial","volume":"18","author":"Yu","year":"2023","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.yexmp.2026.105031_bb1245","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","article-title":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity","volume":"19","author":"Zhang","year":"2018","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb1250","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yexcr.2018.09.013","article-title":"The functional potency of natural killer cells in response to IL-2\/IL-15\/IL-21 stimulation is limited by a concurrent upregulation of Tim-3 in bladder cancer","volume":"372","author":"Zhang","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.yexmp.2026.105031_bb1255","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12943-020-01222-5","article-title":"Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol Cancer"},{"issue":"10","key":"10.1016\/j.yexmp.2026.105031_bb1260","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1111\/cas.15932","article-title":"Single-cell RNA-seq reveals a microenvironment and an exhaustion state of T\/NK cells in acute myeloid leukemia","volume":"114","author":"Zhang","year":"2023","journal-title":"Cancer Sci."},{"issue":"101","key":"10.1016\/j.yexmp.2026.105031_bb1265","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adp7302","article-title":"Palmitoylation of TIM-3 promotes immune exhaustion and restrains antitumor immunity","volume":"9","author":"Zhang","year":"2024","journal-title":"Sci Immunol."},{"key":"10.1016\/j.yexmp.2026.105031_bb1270","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115136","article-title":"Intrinsic and extrinsic factors determining natural killer cell fate: phenotype and function","volume":"165","author":"Zhi","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.yexmp.2026.105031_bb1275","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.stem.2020.05.008","article-title":"Metabolic reprograming via deletion of CISH in human iPSC-derived NK cells promotes in vivo persistence and enhances anti-tumor activity","volume":"27","author":"Zhu","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"24","key":"10.1016\/j.yexmp.2026.105031_bb1280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413413","article-title":"Tumor metabolic reprogramming and Ferroptosis: the impact of glucose, protein, and lipid metabolism","volume":"25","author":"Zhu","year":"2024","journal-title":"Int. J. Mol. Sci."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480026000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:38:44Z","timestamp":1783021124000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480026000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":256,"alternative-id":["S0014480026000109"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105031","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms and strategies for reversing NK cell exhaustion in tumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2026.105031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105031"}}